tiprankstipranks
Trending News
More News >
Summit Therapeutics (SMMT)
NASDAQ:SMMT
US Market
Advertisement

Summit Therapeutics (SMMT) Similar Stocks

Compare
1,684 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Summit Therapeutics
$18.89
$14.03B
-13.78%
11 Buy
1 Hold
3 Sell
Moderate Buy
Incyte
$86.53
$16.90B
19.67
34.95%
8 Buy
9 Hold
1 Sell
Moderate Buy
United Therapeutics
$417.57
$18.89B
16.30
17.43%
8 Buy
4 Hold
0 Sell
Moderate Buy
Ascendis Pharma
$197.68
$11.97B
34.84%
16 Buy
0 Hold
0 Sell
Strong Buy
Genmab
$28.28
$17.48B
14.00
17.15%
4 Buy
2 Hold
1 Sell
Moderate Buy
BioNTech SE
$96.22
$23.13B
-14.89%
12 Buy
4 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
SMMT
Summit Therapeutics
18.89
-3.02
-13.78%
INCY
Incyte
86.53
22.41
34.95%
UTHR
United Therapeutics
417.57
61.98
17.43%
ASND
Ascendis Pharma
197.68
51.08
34.84%
GMAB
Genmab
28.28
4.14
17.15%
BNTX
BioNTech SE
96.22
-16.83
-14.89%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis